Rituximab, IVIG, and Plasma Exchange Without Graft Local Infusion Treatment: A New Protocol in ABO Incompatible Living Donor Liver Transplantation
Toru Ikegami(Jikei University School of Medicine), Yoshihiko Maehara(Kyushu University), Hideaki Uchiyama(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Yuji Soejima(Shinshu University), Tomohiro Iguchi(Fukuoka Higashi Medical Center), Akinobu Taketomi(Hokkaido University), Noboru Harada(Kyushu University), Naotaka Hashimoto(Kyushu University)
Cited by 108
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244